Sign Up to like & get
recommendations!
0
Published in 2024 at "JAMA dermatology"
DOI: 10.1001/jamadermatol.2024.4567
Abstract: This Viewpoint describes what dermatologists should know about doxycycline postexposure prophylaxis (doxyPEP) for bacterial sexually transmitted infection (STI) prevention, specifically syphilis, chlamydia, and gonorrhea.
read more here.
Keywords:
sti prevention;
postexposure prophylaxis;
doxycycline postexposure;
prophylaxis doxypep ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Infectious disease clinics of North America"
DOI: 10.1016/j.idc.2021.04.009
Abstract: Health care personnel (HCP) are at risk of exposure to infectious agents depending on their job duties and other factors. Risks include percutaneous exposure to blood-borne pathogens via sharp injuries (eg, human immunodeficiency virus, hepatitis…
read more here.
Keywords:
occupational health;
postexposure prophylaxis;
health update;
update evaluation ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2024 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofae332
Abstract: Abstract Postexposure prophylaxis (PEP) is an important tool for preventing HIV infection but remains underutilized. In this narrative review, we aim to summarize the frequency of missed opportunities for prescribing PEP among studies from around…
read more here.
Keywords:
missed opportunities;
postexposure prophylaxis;
narrative review;
pep ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2024 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofae436
Abstract: Abstract We report the experience of bictegravir/emtricitabine/tenofovir alafenamide for nonoccupational postexposure prophylaxis in sexual assault cases. Between June 2021 and October 2023, 39 individuals completed the 28-day follow-up; 41% experienced some side effects, and 1…
read more here.
Keywords:
sexual assault;
emtricitabine tenofovir;
postexposure prophylaxis;
tenofovir alafenamide ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Pediatric Infectious Disease Journal"
DOI: 10.1097/inf.0000000000002357
Abstract: Using retrospectively collected data from 383 infants born to HIV-1-infected mothers receiving antiretroviral therapy, we compared transmission rates and hematologic toxicity between infants receiving 2-week (short course) versus longer duration zidovudine postexposure prophylaxis. Short course…
read more here.
Keywords:
hematologic toxicity;
postexposure prophylaxis;
short course;
transmission ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "AIDS"
DOI: 10.1097/qad.0000000000001447
Abstract: Objectives: Completion rates for HIV postexposure prophylaxis (PEP) are often low. We investigated the adherence and safety of dolutegravir (DTG; 50 mg daily) with tenofovir disoproxil fumarate–emtricitabine (TDF–FTC; 300/200 mg, respectively) as three-drug PEP in gay and…
read more here.
Keywords:
bisexual men;
gay bisexual;
hiv;
tenofovir disoproxil ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "AIDS"
DOI: 10.1097/qad.0000000000002446
Abstract: ow naded rom httpsournals.lw w om /aionline by bM EG fG 5G U b5FW ZkaBa4M gZ5lG R upam C uD Zs4bsVZvW ITw D Y1nD iSaXU 4N 3O 1U qhA/XhH VezeFgLM 1m FlM 7T6/D ddtc2LJ59PC 6gVU…
read more here.
Keywords:
hiv persons;
prevention hiv;
persons low;
prophylaxis ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "AIDS"
DOI: 10.1097/qad.0000000000003258
Abstract: Postexposure prophylaxis (PEP) is a World Health Organisation-endorsed approach to prevent HIV acquisition from a recent sexual exposure by initiating an antiretroviral drug regimen, within 72 h after the exposure, but ideally within 24 h,…
read more here.
Keywords:
timely hiv;
enabling timely;
postexposure prophylaxis;
postexposure ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Pathogens"
DOI: 10.3390/pathogens11080882
Abstract: Monoclonal antibodies are laboratory-made proteins that mimic the immune system’s ability to fight off harmful microorganisms, including viruses such as Severe Acute Respiratory Syndrome-CoronaVirus-2 (SARS-CoV-2). The US Food and Drug Administration (FDA) and the European…
read more here.
Keywords:
covid;
prophylaxis;
postexposure prophylaxis;
monoclonal antibodies ... See more keywords